162 related articles for article (PubMed ID: 8027981)
1. Synthesis and characterization of selective fluorescent ligands for the neurokinin NK2 receptor.
Bradshaw CG; Ceszkowski K; Turcatti G; Beresford IJ; Chollet A
J Med Chem; 1994 Jun; 37(13):1991-5. PubMed ID: 8027981
[TBL] [Abstract][Full Text] [Related]
2. Probing the binding domain of the NK2 receptor with fluorescent ligands: evidence that heptapeptide agonists and antagonists bind differently.
Turcatti G; Vogel H; Chollet A
Biochemistry; 1995 Mar; 34(12):3972-80. PubMed ID: 7696262
[TBL] [Abstract][Full Text] [Related]
3. Probing the structure and function of the tachykinin neurokinin-2 receptor through biosynthetic incorporation of fluorescent amino acids at specific sites.
Turcatti G; Nemeth K; Edgerton MD; Meseth U; Talabot F; Peitsch M; Knowles J; Vogel H; Chollet A
J Biol Chem; 1996 Aug; 271(33):19991-8. PubMed ID: 8702716
[TBL] [Abstract][Full Text] [Related]
4. MEN 11420 (Nepadutant), a novel glycosylated bicyclic peptide tachykinin NK2 receptor antagonist.
Catalioto RM; Criscuoli M; Cucchi P; Giachetti A; Gianotti D; Giuliani S; Lecci A; Lippi A; Patacchini R; Quartara L; Renzetti AR; Tramontana M; Arcamone F; Maggi CA
Br J Pharmacol; 1998 Jan; 123(1):81-91. PubMed ID: 9484857
[TBL] [Abstract][Full Text] [Related]
5. GR159897, a potent non-peptide antagonist at tachykinin NK2 receptors.
Beresford IJ; Sheldrick RL; Ball DI; Turpin MP; Walsh DM; Hawcock AB; Coleman RA; Hagan RM; Tyers MB
Eur J Pharmacol; 1995 Jan; 272(2-3):241-8. PubMed ID: 7713168
[TBL] [Abstract][Full Text] [Related]
6. Fluorescent probes for dopamine receptors: synthesis and characterization of fluorescein and 7-nitrobenz-2-oxa-1,3-diazol-4-yl conjugates of D-1 and D-2 receptor ligands.
Bakthavachalam V; Baindur N; Madras BK; Neumeyer JL
J Med Chem; 1991 Nov; 34(11):3235-41. PubMed ID: 1956042
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and characterization of fluorescent antagonists and agonists for human oxytocin and vasopressin V(1)(a) receptors.
Terrillon S; Cheng LL; Stoev S; Mouillac B; Barberis C; Manning M; Durroux T
J Med Chem; 2002 Jun; 45(12):2579-88. PubMed ID: 12036367
[TBL] [Abstract][Full Text] [Related]
8. Fluorescent pseudo-peptide linear vasopressin antagonists: design, synthesis, and applications.
Durroux T; Peter M; Turcatti G; Chollet A; Balestre MN; Barberis C; Seyer R
J Med Chem; 1999 Apr; 42(7):1312-9. PubMed ID: 10197974
[TBL] [Abstract][Full Text] [Related]
9. MEN15596, a novel nonpeptide tachykinin NK2 receptor antagonist.
Cialdai C; Tramontana M; Patacchini R; Lecci A; Catalani C; Catalioto RM; Meini S; Valenti C; Altamura M; Giuliani S; Maggi CA
Eur J Pharmacol; 2006 Nov; 549(1-3):140-8. PubMed ID: 16979621
[TBL] [Abstract][Full Text] [Related]
10. Rational design of high affinity tachykinin NK2 receptor antagonists.
Boyle S; Guard S; Hodgson J; Horwell DC; Howson W; Hughes J; McKnight A; Martin K; Pritchard MC; Watling KJ
Bioorg Med Chem; 1994 Feb; 2(2):101-13. PubMed ID: 7922121
[TBL] [Abstract][Full Text] [Related]
11. Pharmacology of an original and selective nonpeptide antagonist ligand for the human tachykinin NK2 receptor.
Meini S; Catalani C; Bellucci F; Cucchi P; Giuliani S; Zappitelli S; Rotondaro L; Pasqui F; Guidi A; Altamura M; Giolitti A; Maggi CA
Eur J Pharmacol; 2005 Jun; 516(2):104-11. PubMed ID: 15925360
[TBL] [Abstract][Full Text] [Related]
12. Novel ligands lacking a positive charge for the delta- and mu-opioid receptors.
Schiller PW; Berezowska I; Nguyen TM; Schmidt R; Lemieux C; Chung NN; Falcone-Hindley ML; Yao W; Liu J; Iwama S; Smith AB; Hirschmann R
J Med Chem; 2000 Feb; 43(4):551-9. PubMed ID: 10691681
[TBL] [Abstract][Full Text] [Related]
13. Highly potent and selective heptapeptide antagonists of the neurokinin NK-2 receptor.
McElroy AB; Clegg SP; Deal MJ; Ewan GB; Hagan RM; Ireland SJ; Jordan CC; Porter B; Ross BC; Ward P
J Med Chem; 1992 Jul; 35(14):2582-91. PubMed ID: 1321907
[TBL] [Abstract][Full Text] [Related]
14. [3H][beta-Ala8]neurokinin A-(4-10): a novel, selective radioligand for the tachykinin NK2 receptor.
Goso C; Astolfi M; Parlani M; Manzini S
Eur J Pharmacol; 1995 Dec; 294(1):239-45. PubMed ID: 8788437
[TBL] [Abstract][Full Text] [Related]
15. MEN 10,627, a novel polycyclic peptide antagonist of tachykinin NK2 receptors.
Maggi CA; Astolfi M; Giuliani S; Goso C; Manzini S; Meini S; Patacchini R; Pavone V; Pedone C; Quartara L
J Pharmacol Exp Ther; 1994 Dec; 271(3):1489-500. PubMed ID: 7996462
[TBL] [Abstract][Full Text] [Related]
16. Characterization of [3H]MEN 11420, a novel glycosylated peptide antagonist radioligand of the tachykinin NK2 receptor.
Renzetti AR; Catalioto RM; Criscuoli M; Cucchi P; Lippi A; Guelfi M; Quartara L; Maggi CA
Biochem Biophys Res Commun; 1998 Jul; 248(1):78-82. PubMed ID: 9675089
[TBL] [Abstract][Full Text] [Related]
17. Harnessing the Anti-Nociceptive Potential of NK2 and NK3 Ligands in the Design of New Multifunctional μ/δ-Opioid Agonist-Neurokinin Antagonist Peptidomimetics.
Gadais C; Piekielna-Ciesielska J; De Neve J; Martin C; Janecka A; Ballet S
Molecules; 2021 Sep; 26(17):. PubMed ID: 34500841
[TBL] [Abstract][Full Text] [Related]
18. Neurokinin 1 and 2 antagonists attenuate the responses and NK1 antagonists prevent the sensitization of primate spinothalamic tract neurons after intradermal capsaicin.
Dougherty PM; Palecek J; Palecková V; Willis WD
J Neurophysiol; 1994 Oct; 72(4):1464-75. PubMed ID: 7823080
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and binding affinities of cyclic and related linear analogues of CCK8 selective for central receptors.
Charpentier B; Dor A; Roy P; England P; Pham H; Durieux C; Roques BP
J Med Chem; 1989 Jun; 32(6):1184-90. PubMed ID: 2724293
[TBL] [Abstract][Full Text] [Related]
20. Biological and conformational examination of stereochemical modifications using the template melanotropin peptide, Ac-Nle-c[Asp-His-Phe-Arg-Trp-Ala-Lys]-NH2, on human melanocortin receptors.
Haskell-Luevano C; Nikiforovich G; Sharma SD; Yang YK; Dickinson C; Hruby VJ; Gantz I
J Med Chem; 1997 May; 40(11):1738-48. PubMed ID: 9171884
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]